Literature DB >> 16201274

SUMO-1 enhancing the p53-induced HepG2 cell apoptosis.

Xingrong Lu1, Jilin Yi.   

Abstract

In order to investigate the effect of small ubiquitin-like modifier-1 (SUMO-1) on the p53-induced HepG2 cell apoptosis, HepG2 cells were transfected by recombinant plasmids as pwtp53, pMDM2 and pSUMO-1 respectively. Western blot was employed to detect the protein expression of the transfected recombinant plasmids and the rate of apoptosis was measured by flow cytometry. The results showed that in cells transfected with pwtp53 and pwtp53 + pSUMO-1, the apoptosis rate was (16.79+/-1.62) % and (18.15+/-1.36) % respectively, while transfected with pwtp53+ pMDM2, the rate was decreased to (5.17+/-1.23) %. The apoptosis rate was (14.06+/-1.84) % in the cells transfected with pwtp53+pMDM2+pSUMO-1, significantly higher than that in the cells Transfected with pwtp53+pMDM2 (P<0.01). The apoptosis rates in the cells were all less than 2 % and had no significant difference among the groups. It was suggested that in the HepG2 cells, SUMO-1 can increase the apoptosis induced by wild-type p53 through binding to p53 protein, posttranslational modification and inhibiting the p53 degradation by MDM2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16201274     DOI: 10.1007/bf02828145

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

1.  SUMO-1 modification activates the transcriptional response of p53.

Authors:  M S Rodriguez; J M Desterro; S Lain; C A Midgley; D P Lane; R T Hay
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

Review 2.  SUMO, ubiquitin's mysterious cousin.

Authors:  S Müller; C Hoege; G Pyrowolakis; S Jentsch
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

Review 3.  SUMO--nonclassical ubiquitin.

Authors:  F Melchior
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

Review 4.  The p53-Mdm2 pathway: targets for the development of new anticancer therapeutics.

Authors:  Daniella I Zheleva; David P Lane; Peter M Fischer
Journal:  Mini Rev Med Chem       Date:  2003-05       Impact factor: 3.862

5.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

Review 6.  p53: puzzle and paradigm.

Authors:  L J Ko; C Prives
Journal:  Genes Dev       Date:  1996-05-01       Impact factor: 11.361

7.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

8.  Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3.

Authors:  H Saitoh; J Hinchey
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

9.  Gene transfer of wild-type p53 results in restoration of tumor-suppressor function in a medulloblastoma cell line.

Authors:  M R Rosenfeld; P Meneses; J Dalmau; M Drobnjak; C Cordon-Cardo; M G Kaplitt
Journal:  Neurology       Date:  1995-08       Impact factor: 9.910

  9 in total
  3 in total

Review 1.  SUMOylation and phosphorylation cross-talk in hepatocellular carcinoma.

Authors:  Maria Lauda Tomasi; Komal Ramani
Journal:  Transl Gastroenterol Hepatol       Date:  2018-04-23

2.  Effects of ursolic acid on the proliferation and apoptosis of human ovarian cancer cells.

Authors:  Xianghong Wang; Liling Li; Bo Wang; Jinyi Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29

3.  Silencing SUMO2 promotes protection against degradation and apoptosis of nucleus pulposus cells through p53 signaling pathway in intervertebral disc degeneration.

Authors:  Liu-Zhong Jin; Ji-Shou Lu; Jian-Wen Gao
Journal:  Biosci Rep       Date:  2018-06-29       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.